{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:47:55Z","timestamp":1790725675125,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014730","name":"Taipei City Government","doi-asserted-by":"crossref","award":["TCH10401-62-040"],"award-info":[{"award-number":["TCH10401-62-040"]}],"id":[{"id":"10.13039\/501100014730","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014730","name":"Taipei City Government","doi-asserted-by":"crossref","award":["10401-62-042"],"award-info":[{"award-number":["10401-62-042"]}],"id":[{"id":"10.13039\/501100014730","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chang-Gung Memorial Hospital, Keelung","award":["CMRPG2D0261"],"award-info":[{"award-number":["CMRPG2D0261"]}]}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.mehy.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T18:11:28Z","timestamp":1447524688000},"page":"97-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Potential benefit of lamotrigine in managing ketamine use disorder"],"prefix":"10.1016","volume":"87","author":[{"given":"Ming-Chyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ken","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-0389","authenticated-orcid":false,"given":"Shih-Ku","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.11.011_b0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2015.11.011_b0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine\u2013its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2015.11.011_b0015","first-page":"215","article-title":"Ketamine and the potential role for rapid-acting antidepressant medications","volume":"137","author":"Krystal","year":"2007","journal-title":"Swiss Med Weekly"},{"key":"10.1016\/j.mehy.2015.11.011_b0020","doi-asserted-by":"crossref","unstructured":"C.G. Abdallah, G. Sanacora, R.S. Duman, J.H. Krystal, Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics, Annu Rev Med (2014).","DOI":"10.1146\/annurev-med-053013-062946"},{"key":"10.1016\/j.mehy.2015.11.011_b0025","first-page":"1","article-title":"Phencyclidine: an overview","author":"Petersen","year":"1978","journal-title":"NIDA Res Monograp"},{"key":"10.1016\/j.mehy.2015.11.011_b0030","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1360-0443.2004.00879.x","article-title":"Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug","volume":"99","author":"Morgan","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2015.11.011_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","article-title":"Patterns of use and harms associated with non-medical ketamine use","volume":"69","author":"Dillon","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mehy.2015.11.011_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2006.09.001","article-title":"Roadside detection of impairment under the influence of ketamine\u2013evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine","volume":"170","author":"Cheng","year":"2007","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.mehy.2015.11.011_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1745-7254.2006.00270.x","article-title":"Recent trends in drug abuse in China","volume":"27","author":"Fang","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.mehy.2015.11.011_b0050","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.addbeh.2007.01.022","article-title":"Polysubstance use and its correlates in adolescent ecstasy users in Taiwan","volume":"32","author":"Yen","year":"2007","journal-title":"Addict Behav"},{"key":"10.1016\/j.mehy.2015.11.011_b0055","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.76.10.5372","article-title":"Specific [3H]phencyclidine binding in rat central nervous system","volume":"76","author":"Zukin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.11.011_b0060","first-page":"13","article-title":"Pharmacologic regulation of the NMDA receptor-ionophore complex","volume":"133","author":"Johnson","year":"1993","journal-title":"NIDA Res Monograp"},{"key":"10.1016\/j.mehy.2015.11.011_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","article-title":"Ketamine","author":"Sinner","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.mehy.2015.11.011_b0070","first-page":"1186","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs","year":"1998","journal-title":"Anesthesia Analgesia"},{"key":"10.1016\/j.mehy.2015.11.011_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2015.11.011_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1747-597X-9-39","article-title":"Gender differences in subjective discontinuation symptoms associated with ketamine use","volume":"9","author":"Chen","year":"2014","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.mehy.2015.11.011_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrurol.2014.22","article-title":"Urological complications of illicit drug use","volume":"11","author":"Skeldon","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.mehy.2015.11.011_b0090","doi-asserted-by":"crossref","first-page":"e43947","DOI":"10.1371\/journal.pone.0043947","article-title":"Chronic ketamine administration modulates midbrain dopamine system in mice","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2015.11.011_b0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/02791072.2001.10400480","article-title":"The nonmedical use of ketamine, part two: a review of problem use and dependence","volume":"33","author":"Jansen","year":"2001","journal-title":"J Psychoactive Drug"},{"key":"10.1016\/j.mehy.2015.11.011_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2008.01.024","article-title":"Journey through the K-hole: phenomenological aspects of ketamine use","volume":"95","author":"Muetzelfeldt","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mehy.2015.11.011_b0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)10377-7","article-title":"Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists","volume":"263","author":"Lu","year":"1992","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.mehy.2015.11.011_b0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1017\/S0033291707002450","article-title":"Attentional bias to incentive stimuli in frequent ketamine users","volume":"38","author":"Morgan","year":"2008","journal-title":"Psychol Med"},{"key":"10.1016\/j.mehy.2015.11.011_b0115","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1360-0443.2006.01494.x","article-title":"A case of ketamine dependence with discontinuation symptoms","volume":"101","author":"Critchlow","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2015.11.011_b0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/17425250903505108","article-title":"Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression","volume":"6","author":"Chen","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.mehy.2015.11.011_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Scientific Committee on Ketamine use: a review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2015.11.011_b0130","first-page":"31","article-title":"Ketamine associated psychedelic effects and dependence","volume":"44","author":"Lim","year":"2003","journal-title":"Singapore Med J"},{"key":"10.1016\/j.mehy.2015.11.011_b0135","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.162.8.1423","article-title":"Anticraving medications for relapse prevention: a possible new class of psychoactive medications","volume":"162","author":"O\u2019Brien","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/187152708786927868","article-title":"Glutamate: the new frontier in pharmacotherapy for cocaine addiction","volume":"7","author":"Uys","year":"2008","journal-title":"CNS Neurol Disord Drug Target"},{"key":"10.1016\/j.mehy.2015.11.011_b0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","article-title":"Glutamatergic medications for the treatment of drug and behavioral addictions","volume":"100","author":"Olive","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2015.11.011_b0150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mp.2011.46","article-title":"New medications for drug addiction hiding in glutamatergic neuroplasticity","volume":"16","author":"Kalivas","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/B978-0-12-385506-0.00009-0","article-title":"Glutamatergic neuroplasticity in cocaine addiction","volume":"98","author":"Uys","year":"2011","journal-title":"Progr Mol Biol Trans Sci"},{"key":"10.1016\/j.mehy.2015.11.011_b0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"Suppl. 10","key":"10.1016\/j.mehy.2015.11.011_b0165","first-page":"18","article-title":"Long-term treatment of bipolar disorder with lamotrigine","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2015.11.011_b0175","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/00001756-200107200-00042","article-title":"Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity","volume":"12","author":"Wang","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.mehy.2015.11.011_b0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0013-9580.2004.02204.x","article-title":"Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine","volume":"45","author":"Pisani","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2015.11.011_b0185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuropharm.2006.09.002","article-title":"Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings","volume":"52","author":"Sitges","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2015.11.011_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00952999809001700","article-title":"A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients","volume":"24","author":"Margolin","year":"1998","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.mehy.2015.11.011_b0195","first-page":"17","article-title":"Reduction in cocaine craving in response to low-dose Lamotrigine in a 39-year-old African American MAN","volume":"3","author":"Shamsi","year":"2006","journal-title":"Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4088\/JCP.v64n0213","article-title":"Lamotrigine in patients with bipolar disorder and cocaine dependence","volume":"64","author":"Brown","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2006.02.001","article-title":"Lamotrigine for bipolar disorder and comorbid cocaine dependence. a replication and extension study","volume":"93","author":"Brown","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2015.11.011_b0210","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2012.90","article-title":"A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence","volume":"37","author":"Brown","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2015.11.011_b0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-5618.2006.00292.x","article-title":"Effects of lamotrigine in patients with bipolar disorder and alcohol dependence","volume":"8","author":"Rubio","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.mehy.2015.11.011_b0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study","volume":"65","author":"Deakin","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.npp.1301057","article-title":"Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens, Neuropsychopharmacology: official publication of the American College of","volume":"32","author":"Razoux","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2015.11.011_b0235","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.11.011_b0240","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ilar.52.3.366","article-title":"The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders","volume":"52","author":"Trujillo","year":"2011","journal-title":"ILAR J"},{"key":"10.1016\/j.mehy.2015.11.011_b0245","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.npp.1300127","article-title":"Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine","volume":"28","author":"Takahata","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771500434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771500434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:57:36Z","timestamp":1748678256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771500434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":49,"alternative-id":["S030698771500434X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.11.011","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential benefit of lamotrigine in managing ketamine use disorder","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}